Tecentriq

Kahr raises $18M to test CD47 drug with Roche's Tecentriq
Kahr raises $18M to test CD47 drug with Roche's Tecentriq
Fierce Biotech
Kahr Medical
anti-CD47
Roche
Tecentriq
Flag link:
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
FDA Grants Priority Review to Roche's Lung Cancer Drug Tecentriq
Motley Fool
Roche
FDA
priority review
Tecentriq
non-squamous non-small cell lung cancer
non-small cell lung cancer
Flag link:
Roche gets Chinese approval for Tecentriq plus chemotherapy to treat ES-SCLC
Roche gets Chinese approval for Tecentriq plus chemotherapy to treat ES-SCLC
Pharmaceutical Business Review
Roche
China
NMPA
Tecentriq
extensive-stage small cell lung cancer
Flag link:
Perioperative use proves elusive for Tecentriq
Perioperative use proves elusive for Tecentriq
EP Vantage
Roche
Tecentriq
Flag link:
Roche's Tecentriq fails trial in form of urothelial cancer
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Roche
Genentech
clinical trials
Tecentriq
urothelial cancer
bladder cancer
Flag link:
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Despite secret discount, Roche's Tecentriq hits NICE roadblock in small-cell lung cancer
Fierce Pharma
Roche
Tecentriq
NICE
UK
Small-Cell Lung Cancer
Flag link:
ESMO I-O: Roche silences Tecentriq doubters with latest lung cancer analysis
ESMO I-O: Roche silences Tecentriq doubters with latest lung cancer analysis
Fierce Pharma
ESMO
Roche
Tecentriq
non-small cell lung cancer
Flag link:
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
SABCS: Merck's Keytruda notches win in triple-negative breast cancer as Roche's Tecentriq falls short
Fierce Pharma
Merck
Ketyruda
Roche
Tecentriq
immuno-oncology
SABCS
triple-negative breast cancer
Flag link:
Roche gets FDA nod for Tecentriq plus chemotherapy to treat metastatic NSCLC
Roche gets FDA nod for Tecentriq plus chemotherapy to treat metastatic NSCLC
Pharmaceutical Business Review
Roche
Tecentriq
metastatic non-squamous non-small cell lung cancer
FDA
Flag link:
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Flag link:
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Fierce Pharma
Roche
liver cancer
Tecentriq
immuno-oncology
Avastin
Nexavar
Flag link:
Roche’s Tecentriq monotherapy significantly improves OS in phase III lung cancer study
Roche’s Tecentriq monotherapy significantly improves OS in phase III lung cancer study
Pharmaceutical Business Review
Roche
Tecentriq
clinical trials
non-small cell lung cancer
Flag link:
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus
EP Vantage
ESMO
Keytruda
Tecentriq
Merck
Roche
Flag link:
Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie
Roche boosts cancer approvals in Europe, pushing for a bigger slice of the I/O pie
Endpoints
Roche
Europe
non-squamous cell non-small cell lung cancer
Tecentriq
Flag link:
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
Endpoints
Roche
Tecentriq
FDA
Europe
Celgene
Abraxane
triple negative breast cancer
Flag link:
Mark Your Calendar For These September PDUFA Dates
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Flag link:
Roche says test showed Tecentriq helped vs bladder cancer
Roche says test showed Tecentriq helped vs bladder cancer
Reuters
Roche
Tecentriq
bladder cancer
Flag link:
Roche closes on EU approval for Tecentriq in breast cancer
Roche closes on EU approval for Tecentriq in breast cancer
Pharmaforum
Roche
Tecentriq
Europe
triple negative breast cancer
Flag link:
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
AZ’s Imfinzi on target in small cell lung cancer, sets up Roche rivalry
Pharmaforum
AstraZeneca
Imfinzi
extensive-stage small cell lung cancer
Roche
Tecentriq
Flag link:
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Roche
Exelixis
Cotellic
Tecentriq
clinical trials
advanced melanoma
Flag link:

Pages